Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

270 Views

Poster Session: HIV: Treatment

1268 - Efficacy, safety, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in adults with HIV-HBV infection - preliminary results

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Co-Author(s)

HK

Helena Kwakwa, M.D.

Newlands Health
Philadelphia, Pennsylvania, United States
JB

Jacqueline Bran, M.S.

Research coordinator
University of Maryland School of Medicine
Baltimore, Maryland, United States
JR

Julia Ruff, R.N.

Newlands Health
Philadelphia, Pennsylvania, United States
SC

Sunny Choe, PhD

Sr. Medical Scientist
Gilead Sciences
Foster City, California, United States

Presenting Author(s)

Joel V. Chua, MD

Assistant Professor of Medicine
University of Maryland School of Medicine
Baltimore, Maryland, United States